Design and Rationale of Routine UltrasouNd GuIdance for Vascular AccEss foR Cardiac Procedures: A Randomized TriaL (UNIVERSAL)

Background: A significant limitation of femoral artery access for cardiac interventions is the increased risk of vascular complications and bleeding compared to radial access. Ultrasound (US)-guided femoral access may reduce major vascular complications and bleeding. We aim to determine whether rout...

Full description

Bibliographic Details
Main Authors: Sulaiman Alrashidi, MD, Marc-André d’Entremont, MD, MPH, Omar Alansari, MD, Jose Winter, MD, Bradley Brochu, MD, Laura Heenan, MSc, Elizabeth Skuriat, MSc, Jessica Tyrwhitt, BSc, Michael Raco, MD, Michael B. Tsang, MD, MSc, Nicholas Valettas, MD, MASc, James Velianou, MD, Tej Sheth, MD, Matthew Sibbald, MD, Ph.D, Shamir R. Mehta, MD, MSc, Natalia Pinilla-Echeverri, MD, MSc, Jon David Schwalm, MD, MSc, Madhu K. Natarajan, MD, MSc, Andrew Kelly, MD, Elie Akl, MD, Sarah Tawadros, MBBCh, Mercedes Camargo, MD, MASc, Walaa Faidi, MSc, Gustavo Dutra, MD, Sanjit S. Jolly, MD, MSc
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:CJC Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2589790X22001676
_version_ 1828167819122966528
author Sulaiman Alrashidi, MD
Marc-André d’Entremont, MD, MPH
Omar Alansari, MD
Jose Winter, MD
Bradley Brochu, MD
Laura Heenan, MSc
Elizabeth Skuriat, MSc
Jessica Tyrwhitt, BSc
Michael Raco, MD
Michael B. Tsang, MD, MSc
Nicholas Valettas, MD, MASc
James Velianou, MD
Tej Sheth, MD
Matthew Sibbald, MD, Ph.D
Shamir R. Mehta, MD, MSc
Natalia Pinilla-Echeverri, MD, MSc
Jon David Schwalm, MD, MSc
Madhu K. Natarajan, MD, MSc
Andrew Kelly, MD
Elie Akl, MD
Sarah Tawadros, MBBCh
Mercedes Camargo, MD, MASc
Walaa Faidi, MSc
Gustavo Dutra, MD
Sanjit S. Jolly, MD, MSc
author_facet Sulaiman Alrashidi, MD
Marc-André d’Entremont, MD, MPH
Omar Alansari, MD
Jose Winter, MD
Bradley Brochu, MD
Laura Heenan, MSc
Elizabeth Skuriat, MSc
Jessica Tyrwhitt, BSc
Michael Raco, MD
Michael B. Tsang, MD, MSc
Nicholas Valettas, MD, MASc
James Velianou, MD
Tej Sheth, MD
Matthew Sibbald, MD, Ph.D
Shamir R. Mehta, MD, MSc
Natalia Pinilla-Echeverri, MD, MSc
Jon David Schwalm, MD, MSc
Madhu K. Natarajan, MD, MSc
Andrew Kelly, MD
Elie Akl, MD
Sarah Tawadros, MBBCh
Mercedes Camargo, MD, MASc
Walaa Faidi, MSc
Gustavo Dutra, MD
Sanjit S. Jolly, MD, MSc
author_sort Sulaiman Alrashidi, MD
collection DOAJ
description Background: A significant limitation of femoral artery access for cardiac interventions is the increased risk of vascular complications and bleeding compared to radial access. Ultrasound (US)-guided femoral access may reduce major vascular complications and bleeding. We aim to determine whether routinely using US guidance for femoral arterial access for coronary angiography or intervention will reduce Bleeding Academic Research Consortium (BARC) 2, 3, or 5 bleeding or major vascular complications. Methods: The Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL) is a multicentre, prospective, open-label, randomized trial with blinded outcomes assessment. Patients undergoing coronary angiography with or without intervention via a femoral approach with fluoroscopic guidance will be randomized 1:1 to US-guided femoral access, compared to no US. The primary outcome is the composite of major bleeding based on the BARC 2, 3, or 5 criteria or major vascular complications within 30 days. The trial is designed to have 80% power and a 2-sided alpha level of 5% to detect a 50% relative risk reduction for the primary outcome based on a control event rate of 14%. Results: We completed enrollment on April 29, 2022, with 621 randomized patients. The patients had a mean age of 71 years (25.4% female), with a high rate of comorbidities, as follows: 45% had a prior percutaneous coronary intervention; 57% had previous coronary artery bypass surgery; and 18% had peripheral vascular disease. Conclusions: The UNIVERSAL trial will be one of the largest randomized trials of US-guided femoral access and has the potential to change guidelines and increase US uptake for coronary procedures worldwide. Résumé: Introduction: Par rapport à l’abord radial, la limitation importante de l’abord artériel fémoral lors des interventions au cœur pose un risque accru de complications vasculaires et de saignements. L’abord fémoral guidé par ultrasons (US) peut contribuer à réduire les complications vasculaires majeures et les saignements. Nous avons pour objectif de déterminer si l’utilisation systématique du guidage par US pour l’abord artériel fémoral lors des angiographies ou des interventions coronariennes contribuera à réduire les saignements de type 2, 3 ou 5 selon le Bleeding Academic Research Consortium (BARC) ou les complications vasculaires majeures. Méthodes: L’Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL) est un essai multicentrique, prospectif, ouvert, à répartition aléatoire, réalisé par une évaluation à l’insu des résultats. Les patients subissant une angiographie coronarienne avec ou sans intervention par voie fémorale sous guidage fluoroscopique seront répartis de façon aléatoire 1:1 à l’abord fémoral guidé par US ou sans US. Le principal critère d’évaluation est le critère composite de saignements majeurs de type 2, 3 ou 5 selon les critères du BARC ou de complications vasculaires majeures dans les 30 jours. L’essai est conçu de façon à avoir une puissance de 80 % et un seuil alpha bilatéral de 5 % pour déterminer la réduction du risque relatif de 50 % du critère d’évaluation principal selon un taux d’événements dans le groupe témoin de 14 %. Résultats: Le 29 avril 2022, nous avons terminé le recrutement de 621 patients choisis aléatoirement. Les patients avaient un âge moyen de 71 ans (25,4 % de femmes) et un taux élevé de comorbidités : 45 % avaient déjà subi une intervention coronarienne percutanée, 57 % avaient déjà subi un pontage aorto-coronarien et 18 % avaient une maladie vasculaire périphérique. Conclusions: L’essai UNIVERSAL qui sera l’un des plus vastes essais à répartition aléatoire sur l’abord fémoral guidé par US a le potentiel de faire changer les lignes directrices et de faire augmenter le recours aux US lors des interventions coronariennes dans le monde entier.
first_indexed 2024-04-12T02:23:37Z
format Article
id doaj.art-c0526a8e4a6f4ae08887bc366378060b
institution Directory Open Access Journal
issn 2589-790X
language English
last_indexed 2024-04-12T02:23:37Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series CJC Open
spelling doaj.art-c0526a8e4a6f4ae08887bc366378060b2022-12-22T03:52:04ZengElsevierCJC Open2589-790X2022-12-0141210741080Design and Rationale of Routine UltrasouNd GuIdance for Vascular AccEss foR Cardiac Procedures: A Randomized TriaL (UNIVERSAL)Sulaiman Alrashidi, MD0Marc-André d’Entremont, MD, MPH1Omar Alansari, MD2Jose Winter, MD3Bradley Brochu, MD4Laura Heenan, MSc5Elizabeth Skuriat, MSc6Jessica Tyrwhitt, BSc7Michael Raco, MD8Michael B. Tsang, MD, MSc9Nicholas Valettas, MD, MASc10James Velianou, MD11Tej Sheth, MD12Matthew Sibbald, MD, Ph.D13Shamir R. Mehta, MD, MSc14Natalia Pinilla-Echeverri, MD, MSc15Jon David Schwalm, MD, MSc16Madhu K. Natarajan, MD, MSc17Andrew Kelly, MD18Elie Akl, MD19Sarah Tawadros, MBBCh20Mercedes Camargo, MD, MASc21Walaa Faidi, MSc22Gustavo Dutra, MD23Sanjit S. Jolly, MD, MSc24McMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Niagara Health, St. Catharines, Ontario, CanadaPopulation Health Research Institute, Hamilton, Ontario, Canada; Centre Hospitalier Universitaire de Sherbrooke (CHUS), Sherbrooke, Quebec, CanadaMcMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Niagara Health, St. Catharines, Ontario, CanadaClinica Alemana de Santiago, Santiago, ChileCK Hui Heart Centre, Royal Alexandra Hospital, Edmonton, Alberta, CanadaPopulation Health Research Institute, Hamilton, Ontario, CanadaPopulation Health Research Institute, Hamilton, Ontario, CanadaPopulation Health Research Institute, Hamilton, Ontario, CanadaMcMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Niagara Health, St. Catharines, Ontario, CanadaMcMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Niagara Health, St. Catharines, Ontario, CanadaMcMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Niagara Health, St. Catharines, Ontario, CanadaMcMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Niagara Health, St. Catharines, Ontario, CanadaMcMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Niagara Health, St. Catharines, Ontario, Canada; Population Health Research Institute, Hamilton, Ontario, CanadaMcMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Niagara Health, St. Catharines, Ontario, CanadaMcMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Niagara Health, St. Catharines, Ontario, Canada; Population Health Research Institute, Hamilton, Ontario, CanadaMcMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Niagara Health, St. Catharines, Ontario, Canada; Population Health Research Institute, Hamilton, Ontario, CanadaMcMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Niagara Health, St. Catharines, Ontario, Canada; Population Health Research Institute, Hamilton, Ontario, CanadaMcMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Niagara Health, St. Catharines, Ontario, Canada; Population Health Research Institute, Hamilton, Ontario, CanadaMcMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Niagara Health, St. Catharines, Ontario, CanadaMcGill University Health Centre, Montreal, Quebec, CanadaHamilton Health Sciences, Hamilton, Ontario, CanadaHamilton Health Sciences, Hamilton, Ontario, CanadaHamilton Health Sciences, Hamilton, Ontario, CanadaMcMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, CanadaMcMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Niagara Health, St. Catharines, Ontario, Canada; Population Health Research Institute, Hamilton, Ontario, Canada; Corresponding author: Dr Sanjit S. Jolly, Population Health Research Institute, Hamilton General Hospital, 237 Barton St. East, Hamilton, Ontario L8L 2X2, Canada. Tel.: +1-905-521-2100 ext. 40309.Background: A significant limitation of femoral artery access for cardiac interventions is the increased risk of vascular complications and bleeding compared to radial access. Ultrasound (US)-guided femoral access may reduce major vascular complications and bleeding. We aim to determine whether routinely using US guidance for femoral arterial access for coronary angiography or intervention will reduce Bleeding Academic Research Consortium (BARC) 2, 3, or 5 bleeding or major vascular complications. Methods: The Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL) is a multicentre, prospective, open-label, randomized trial with blinded outcomes assessment. Patients undergoing coronary angiography with or without intervention via a femoral approach with fluoroscopic guidance will be randomized 1:1 to US-guided femoral access, compared to no US. The primary outcome is the composite of major bleeding based on the BARC 2, 3, or 5 criteria or major vascular complications within 30 days. The trial is designed to have 80% power and a 2-sided alpha level of 5% to detect a 50% relative risk reduction for the primary outcome based on a control event rate of 14%. Results: We completed enrollment on April 29, 2022, with 621 randomized patients. The patients had a mean age of 71 years (25.4% female), with a high rate of comorbidities, as follows: 45% had a prior percutaneous coronary intervention; 57% had previous coronary artery bypass surgery; and 18% had peripheral vascular disease. Conclusions: The UNIVERSAL trial will be one of the largest randomized trials of US-guided femoral access and has the potential to change guidelines and increase US uptake for coronary procedures worldwide. Résumé: Introduction: Par rapport à l’abord radial, la limitation importante de l’abord artériel fémoral lors des interventions au cœur pose un risque accru de complications vasculaires et de saignements. L’abord fémoral guidé par ultrasons (US) peut contribuer à réduire les complications vasculaires majeures et les saignements. Nous avons pour objectif de déterminer si l’utilisation systématique du guidage par US pour l’abord artériel fémoral lors des angiographies ou des interventions coronariennes contribuera à réduire les saignements de type 2, 3 ou 5 selon le Bleeding Academic Research Consortium (BARC) ou les complications vasculaires majeures. Méthodes: L’Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL) est un essai multicentrique, prospectif, ouvert, à répartition aléatoire, réalisé par une évaluation à l’insu des résultats. Les patients subissant une angiographie coronarienne avec ou sans intervention par voie fémorale sous guidage fluoroscopique seront répartis de façon aléatoire 1:1 à l’abord fémoral guidé par US ou sans US. Le principal critère d’évaluation est le critère composite de saignements majeurs de type 2, 3 ou 5 selon les critères du BARC ou de complications vasculaires majeures dans les 30 jours. L’essai est conçu de façon à avoir une puissance de 80 % et un seuil alpha bilatéral de 5 % pour déterminer la réduction du risque relatif de 50 % du critère d’évaluation principal selon un taux d’événements dans le groupe témoin de 14 %. Résultats: Le 29 avril 2022, nous avons terminé le recrutement de 621 patients choisis aléatoirement. Les patients avaient un âge moyen de 71 ans (25,4 % de femmes) et un taux élevé de comorbidités : 45 % avaient déjà subi une intervention coronarienne percutanée, 57 % avaient déjà subi un pontage aorto-coronarien et 18 % avaient une maladie vasculaire périphérique. Conclusions: L’essai UNIVERSAL qui sera l’un des plus vastes essais à répartition aléatoire sur l’abord fémoral guidé par US a le potentiel de faire changer les lignes directrices et de faire augmenter le recours aux US lors des interventions coronariennes dans le monde entier.http://www.sciencedirect.com/science/article/pii/S2589790X22001676
spellingShingle Sulaiman Alrashidi, MD
Marc-André d’Entremont, MD, MPH
Omar Alansari, MD
Jose Winter, MD
Bradley Brochu, MD
Laura Heenan, MSc
Elizabeth Skuriat, MSc
Jessica Tyrwhitt, BSc
Michael Raco, MD
Michael B. Tsang, MD, MSc
Nicholas Valettas, MD, MASc
James Velianou, MD
Tej Sheth, MD
Matthew Sibbald, MD, Ph.D
Shamir R. Mehta, MD, MSc
Natalia Pinilla-Echeverri, MD, MSc
Jon David Schwalm, MD, MSc
Madhu K. Natarajan, MD, MSc
Andrew Kelly, MD
Elie Akl, MD
Sarah Tawadros, MBBCh
Mercedes Camargo, MD, MASc
Walaa Faidi, MSc
Gustavo Dutra, MD
Sanjit S. Jolly, MD, MSc
Design and Rationale of Routine UltrasouNd GuIdance for Vascular AccEss foR Cardiac Procedures: A Randomized TriaL (UNIVERSAL)
CJC Open
title Design and Rationale of Routine UltrasouNd GuIdance for Vascular AccEss foR Cardiac Procedures: A Randomized TriaL (UNIVERSAL)
title_full Design and Rationale of Routine UltrasouNd GuIdance for Vascular AccEss foR Cardiac Procedures: A Randomized TriaL (UNIVERSAL)
title_fullStr Design and Rationale of Routine UltrasouNd GuIdance for Vascular AccEss foR Cardiac Procedures: A Randomized TriaL (UNIVERSAL)
title_full_unstemmed Design and Rationale of Routine UltrasouNd GuIdance for Vascular AccEss foR Cardiac Procedures: A Randomized TriaL (UNIVERSAL)
title_short Design and Rationale of Routine UltrasouNd GuIdance for Vascular AccEss foR Cardiac Procedures: A Randomized TriaL (UNIVERSAL)
title_sort design and rationale of routine ultrasound guidance for vascular access for cardiac procedures a randomized trial universal
url http://www.sciencedirect.com/science/article/pii/S2589790X22001676
work_keys_str_mv AT sulaimanalrashidimd designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT marcandredentremontmdmph designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT omaralansarimd designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT josewintermd designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT bradleybrochumd designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT lauraheenanmsc designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT elizabethskuriatmsc designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT jessicatyrwhittbsc designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT michaelracomd designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT michaelbtsangmdmsc designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT nicholasvalettasmdmasc designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT jamesvelianoumd designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT tejshethmd designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT matthewsibbaldmdphd designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT shamirrmehtamdmsc designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT nataliapinillaecheverrimdmsc designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT jondavidschwalmmdmsc designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT madhuknatarajanmdmsc designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT andrewkellymd designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT elieaklmd designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT sarahtawadrosmbbch designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT mercedescamargomdmasc designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT walaafaidimsc designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT gustavodutramd designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal
AT sanjitsjollymdmsc designandrationaleofroutineultrasoundguidanceforvascularaccessforcardiacproceduresarandomizedtrialuniversal